Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Hetlioz symbols : VNDA save search
Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia
Published: 2024-03-06 (Crawled : 12:00) - prnewswire.com
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: -1.21%
H: 0.0%
C: -4.4%
hetlioz fda update treatment pharmaceuticals
Vanda Pharmaceuticals Intends to Petition the U.S. Supreme Court in its HETLIOZ® ANDA Litigation
Published: 2023-10-20 (Crawled : 11:00) - prnewswire.com
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: -0.23%
H: 2.79%
C: 0.93%
hetlioz pharmaceuticals
Vanda Pharmaceuticals Responds to Ruling in HETLIOZ® ANDA Litigation
Published: 2022-12-13 (Crawled : 01:00) - biospace.com/
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 1.85%
H: 0.18%
C: -32.39%
hetlioz pharmaceuticals
VANDA PHARMACEUTICALS ANNOUNCES NOTICE OF OPPORTUNITY FOR AN FDA HEARING ON THE sNDA FOR HETLIOZ® IN JET LAG DISORDER
Published: 2022-09-07 (Crawled : 23:00) - prnewswire.com
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 0.0%
H: 1.51%
C: -0.68%
hetlioz fda
Vanda Pharmaceuticals Settles HETLIOZ® Patent Litigation with MSN
Published: 2022-01-14 (Crawled : 14:00) - prnewswire.com
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: -0.55%
H: 0.0%
C: 0.0%
hetlioz als patent
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.